Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Impact Biomedical's COVID-19 research published in peer-reviewed scientific journal

SGX-listed Singapore eDevelopment Limited's wholly owned subsidiary Impact Biomedical Inc. announced today that their COVID-19 research with Global Research and Discovery Group Sciences, conducted in collaboration with Harvard Medical School and Vilotos Pharmaceutical, Inc., was published in the peer-reviewed scientific journal Molecules on June 11, 2020.

18 Jun 2020

Avacta provides update on Affimer therapy for COVID-19 infection

Avacta Group plc, is pleased to announce that collaborative work with the University of Glasgow has shown that Affimer reagents prevent infection.

From Avacta Life Sciences Ltd. 18 Jun 2020

Swiss-based VirtaMed provides surgical training in hospitals with mobile simulation lab

As Switzerland enters Phase 3 of COVID-19 restrictions, Zurich-based VirtaMed brings medical training to hospitals across the country with a mobile surgical simulation lab.

From VirtaMed 18 Jun 2020

COVID-19 and blood group in aortic valve replacement

The COVID-19 pandemic has been found to cause disproportionate harm in patients with cardiovascular disease, especially among the elderly population, among other risk factors. However, a new study published on the preprint server medRxiv* in June 2020 is the first to report its clinical features in patients with aortic stenosis who have had a transcatheter aortic valve replacement (TAVR).

18 Jun 2020

COVID-19 could trigger diabetes in healthy people

The coronavirus disease (COVID-19) causes severe illness in people with underlying health conditions, such as heart disease, hypertension, lung illness, and diabetes. Now, scientists warn that viral infection may trigger the development of diabetes in healthy people.

18 Jun 2020

SARS-CoV-2 found in river water, flags risk for humans, wildlife and livestock

Now, a new study by scientists in Ecuador and published on the preprint server medRxiv in June 2020 shows that the virus is present in river water too, which could imply a significant transmission risk in developing countries with inadequate sanitation facilities.

17 Jun 2020

Globally, 350 million could be at risk of severe COVID-19 and hospitalization

Now, a new study shows that one in five individuals is at risk of getting a severe case of COVID-19 due to the presence of underlying disease. The study appeared in the latest issue of The Lancet Global Health this week.

17 Jun 2020

Nanofiber face masks maintain filtration efficiency after washing

With the global spread of coronavirus infections, personal protective equipments especially hygeine face masks are receiving much attention. Masks are essential items for the primary protection of the respiratory tract from viruses and bacteria that are transmitted through the air as droplets.

17 Jun 2020

Researchers use cellular nanosponges to soak up SARS-CoV-2

Scientists are working overtime to find an effective treatment for COVID-19, the illness caused by the new coronavirus, SARS-CoV-2.

17 Jun 2020

Can a toilet flush spread coronavirus?

A new study by Chinese researchers at Yangzhou University shows how fluid dynamics can predict if flushing a toilet with the lid open could lead to the transmission of a virus. The study titled, “Can a toilet promote virus transmission? From a fluid dynamics perspective,” was published in the latest issue of the journal, The Journal of Acoustical Society of America (JASA).

17 Jun 2020

NAU research centers receive grants from Flinn Foundation to support COVID-19 response

Scientists at two Northern Arizona University research centers--the Pathogen and Microbiome Institute and the Center for Health Equity Research--recently received grants totaling $175,000 from the Flinn Foundation in support of projects directed at responding to the COVID-19 threat.

17 Jun 2020

Low potassium levels in COVID-19 disease

Now a new study by an Italian team of researchers published in June 2020 on the preprint server medRxiv reports that potassium levels are often low in COVID-19 disease, mostly due to the urinary loss of potassium.

17 Jun 2020

Integrin-binding peptide ATN-161: Potential COVID-19 treatment

Now, a new study by researchers at Tulane University and published on the preprint server bioRxiv* in June 2020 reports the potential role of an integrin inhibitor ATN-161 to prevent ACE2-S protein binding.

17 Jun 2020

ACE2 and pattern recognition receptor genes increase with age

A recent study by researchers in California and published on the preprint server bioRxiv* in June 2020 shows that advancing age is associated with increased expression of pattern recognition receptor (PRR) genes and ACE2 receptors, possibly accounting in part for the increased severity of the disease in older adults.

17 Jun 2020

A new system for detecting antibodies within minutes

To defend the body, the immune system makes proteins known as antibodies that latch onto the perceived threat, be it HIV, the new coronavirus or, as is the case in autoimmune disease, part of the body itself.

17 Jun 2020

Benefits of convalescent plasma for COVID-19 patients still remain unclear

With vaccines and therapeutic drugs for COVID-19 still under development, doctors are wondering whether antibody-rich plasma infusions from the blood of recovered patients could be a more immediate way to keep hospitalized patients alive and off ventilators.

17 Jun 2020

Highly conserved RNA structures are essential for SARS-CoV-2 replication and pathogenesis

A recent study from the University of North Carolina at Chapel Hill revealed how selective pressure helps in preserving secondary RNA structures in coronavirus genomes, unveiling a pivotal role of these elements in viral replication and pathogenesis. The paper is currently available on the bioRxiv* preprint server.

17 Jun 2020

Trump’s take on COVID testing misses public health realities

President Donald Trump sought to downplay the numbers associated with COVID-19 in the United States — which have passed 2 million confirmed cases and are nearing 120,000 lives lost — by arguing that the soaring national count was simply the result of superior testing.

17 Jun 2020

“Catch and kill” ventilation device destroys SARS-CoV-2, potential for airplanes - cruise ships

Researchers in Texas have developed an air conditioning system that can “catch and kill” severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) in an effort to help both essential works and the public combat coronavirus disease 2019 (COVID-19).

17 Jun 2020

Scientists examine SARS-CoV-2 cell entry in different species

Researchers in China have demonstrated the ability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to interact with the host cell receptors of multiple species of animals.

17 Jun 2020